Purchase Order 75F40122P00340

Award Date 9/19/22
Potential Completion Date 2/29/28
Potential Value $147K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, MA 02090, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $90,324.00 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Nanion Technologies Inc., a small business vendor. The contract is for the provision of a Real Time Cell Analysis Cardio System to support the monitoring of drug-induced cardiotoxicity. The system will be used to perform advanced cellular research and drug discovery studies at the FDA's facilities in Silver Spring, Maryland. The contract was set aside for small business competition,...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed price purchase order contract worth $249,210.00 to Molecular Devices LLC, a subsidiary of Danaher Corporation, for an ImageXpress Micro 4 High Content Screening System. The system is intended to enable the FDA's National Center for Toxicological Research to perform measurements of intracellular calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes to better understand the mechanisms...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $111,539.32 firm-fixed-price purchase order to EHT Technologies GMBH, a for-profit limited liability company manufacturer, for a Test System of Engineered Heart Tissues (EHT). This system will be used by the FDA's Division of Applied Regulatory Science to study variations in heart cell contractility resulting from exposure to certain drugs or drug combinations in a more mature setting. The contract...
This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
The Department of Health and Human Services' Food and Drug Administration awarded a firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for an INCUCYTE S3 LIVE-CELL ANALYSIS SYSTEM or equivalent. The $134,622.30 contract will be performed in Herndon, Virginia and supports the FDA's Division of Applied Regulatory Science in studying the chronic effects of drugs on cell cultures containing human organ features. Government Scientific Source Inc. is a leading...
This is a firm fixed-price purchase order awarded by the Uniformed Services University of the Health Sciences, a defense agency, to Ionoptix LLC, a for-profit vendor, for an IONOPTIX MYOCYTE CALCIUM & CONTRACTILITY SYSTEM. The contract has a ceiling value of $37,670.00 and a completion date of March 5, 2010. Based on Ionoptix's history of federal contract awards, they have provided specialized biomedical research equipment and systems to several government agencies, including the...
<p>The Department of Health and Human Services Food and Drug Administration awarded a $175,000.00 firm fixed price purchase order to Cytobioscience, Inc., a for-profit organization, to upgrade the agency's in-house automated patch clamp system. The contract was awarded on September 2, 2018, with a completion date of November 30, 2018. The contract was not set aside for any specific socioeconomic category.</p>
The U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $114,087.00 firm fixed-price purchase order to Maxcyte, Inc., a small business company, for the provision of an electroporator and scalable transfection system. This contract supports the FDA's biomedical research and regulatory missions, as Maxcyte has provided similar specialized laboratory equipment and technologies, such as cell processing systems, electroporation and scalable transfection...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to R &amp; D Enterprises, Inc., a for-profit small business. The contract, worth $95,980.00, is for the delivery of various scientific instruments and accessories used in bio-processing, research, and testing, such as mass spectrometers, thermal conductivity testers, rheometers, colorimeters, thermomechanical analyzers, and titration calorimeters. The contract has an...
The Department of Health and Human Services Food and Drug Administration awarded a $346,227.62 firm-fixed-price purchase order contract to Nanion Technologies Inc., a for-profit corporation specializing in scientific instrumentation and electrophysiology equipment. The five-year service maintenance contract is for Nanion's SyncroPatch 384 system, providing preventative maintenance, technical support, software upgrades, and repairs. This requirement did not have a set-aside designation. Nanion, a...

The Department of Health and Human Services' Food and Drug Administration awarded a purchase order to Ionoptix LLC, a for-profit organization, for the procurement of a Calcium and Contractility System plus four years of preventative maintenance. The potential value of the contract is $147,020.00 and it has a completion date of February 29, 2028. The contract is a firm fixed-price contract with no set-aside designation.

The original solicitation was a pre-solicitation notice for a sole source acquisition of a Real Time Cell Analysis System (xCELLigence) from Agilent Technologies Inc. by the FDA, citing the authority of 41 USC 3304(a)(1) and FAR Subpart 6.302-1. This suggests that the Calcium and Contractility System procured under the current award is related to the FDA's biomedical research activities, which may include areas such as drug development and evaluation.

Generated 3/26/24, 7:31 PM